162 related articles for article (PubMed ID: 22554523)
41. PKCdelta protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis.
Zhang J; Liu N; Zhang J; Liu S; Liu Y; Zheng D
J Cell Biochem; 2005 Oct; 96(3):522-32. PubMed ID: 16114000
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
43. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
[TBL] [Abstract][Full Text] [Related]
44. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
45. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.
Sivaprasad U; Shankar E; Basu A
Cell Death Differ; 2007 Apr; 14(4):851-60. PubMed ID: 17186022
[TBL] [Abstract][Full Text] [Related]
47. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.
Sonnemann J; Gekeler V; Sagrauske A; Müller C; Hofmann HP; Beck JF
Int J Oncol; 2004 Oct; 25(4):1171-81. PubMed ID: 15375570
[TBL] [Abstract][Full Text] [Related]
48. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
49. The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms.
Beranova L; Pombinho AR; Spegarova J; Koc M; Klanova M; Molinsky J; Klener P; Bartunek P; Andera L
Apoptosis; 2013 Jun; 18(6):739-50. PubMed ID: 23456623
[TBL] [Abstract][Full Text] [Related]
50. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.
Thapa B; Bahadur Kc R; Uludağ H
Int J Cancer; 2018 Feb; 142(3):597-606. PubMed ID: 28960310
[TBL] [Abstract][Full Text] [Related]
51. Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
Eustace AJ; Conlon NT; McDermott MSJ; Browne BC; O'Leary P; Holmes FA; Espina V; Liotta LA; O'Shaughnessy J; Gallagher C; O'Driscoll L; Rani S; Madden SF; O'Brien NA; Ginther C; Slamon D; Walsh N; Gallagher WM; Zagozdzon R; Watson WR; O'Donovan N; Crown J
BMC Cancer; 2018 Oct; 18(1):965. PubMed ID: 30305055
[TBL] [Abstract][Full Text] [Related]
52. Identification of plant extracts sensitizing breast cancer cells to TRAIL.
Abdelhamed S; Yokoyama S; Hafiyani L; Kalauni SK; Hayakawa Y; Awale S; Saiki I
Oncol Rep; 2013 May; 29(5):1991-8. PubMed ID: 23426404
[TBL] [Abstract][Full Text] [Related]
53. Resistance to TRAIL in mantle cell lymphoma cells is associated with the decreased expression of purine metabolism enzymes.
Pospisilova J; Vit O; Lorkova L; Klanova M; Zivny J; Klener P; Petrak J
Int J Mol Med; 2013 May; 31(5):1273-9. PubMed ID: 23503700
[TBL] [Abstract][Full Text] [Related]
54. Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL.
Jancekova B; Ondrouskova E; Knopfova L; Smarda J; Benes P
Tumour Biol; 2016 Aug; 37(8):10685-96. PubMed ID: 26867770
[TBL] [Abstract][Full Text] [Related]
55. Stiffness changes of tumor HEp2 cells correlates with the inhibition and release of TRAIL-induced apoptosis pathways.
Targosz-Korecka M; Biedron R; Szczygiel AM; Brzezinka G; Szczerbinski J; Zuk A
J Mol Recognit; 2012 May; 25(5):299-308. PubMed ID: 22528192
[TBL] [Abstract][Full Text] [Related]
56. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
Aliabadi HM; Mahdipoor P; Uludağ H
Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477
[TBL] [Abstract][Full Text] [Related]
57. Clitocine potentiates TRAIL-mediated apoptosis in human colon cancer cells by promoting Mcl-1 degradation.
Sun JG; Ruan F; Zeng XL; Xiang J; Li X; Wu P; Fung KP; Liu FY
Apoptosis; 2016 Oct; 21(10):1144-57. PubMed ID: 27421828
[TBL] [Abstract][Full Text] [Related]
58. Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening.
Garimella SV; Gehlhaus K; Dine JL; Pitt JJ; Grandin M; Chakka S; Nau MM; Caplen NJ; Lipkowitz S
Breast Cancer Res; 2014 Apr; 16(2):R41. PubMed ID: 24745479
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
[TBL] [Abstract][Full Text] [Related]
60. Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells.
Kim SY; Park SE; Shim SM; Park S; Kim KK; Jeong SY; Choi EK; Hwang JJ; Jin DH; Chung CD; Kim I
PLoS One; 2015; 10(12):e0146073. PubMed ID: 26720004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
